AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,832,031 | +176.3% | 75,613 | +59.9% | 0.33% | +233.3% |
Q3 2022 | $2,111,000 | -23.0% | 47,300 | -33.9% | 0.10% | -11.6% |
Q2 2022 | $2,742,000 | +177.2% | 71,600 | +199.6% | 0.11% | +211.1% |
Q1 2022 | $989,000 | -63.3% | 23,900 | -66.5% | 0.04% | -62.5% |
Q4 2021 | $2,692,000 | +48.4% | 71,249 | +29.5% | 0.10% | +24.7% |
Q3 2021 | $1,814,000 | +340.3% | 55,038 | +802.3% | 0.08% | +352.9% |
Q2 2021 | $412,000 | -36.7% | 6,100 | -47.0% | 0.02% | -37.0% |
Q1 2021 | $651,000 | -43.3% | 11,500 | -18.4% | 0.03% | -40.0% |
Q4 2020 | $1,149,000 | +15.9% | 14,100 | +1.4% | 0.04% | -4.3% |
Q3 2020 | $991,000 | -72.3% | 13,900 | -68.0% | 0.05% | -76.7% |
Q2 2020 | $3,578,000 | +316.0% | 43,491 | +197.9% | 0.20% | +201.5% |
Q1 2020 | $860,000 | -96.8% | 14,600 | -94.4% | 0.07% | -95.5% |
Q4 2019 | $26,762,000 | – | 258,948 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |